Press "Enter" to skip to content

Penn State clarifies claim related to Big Ten athletes and myocarditis


CLOSE

Sports Pulse: With everything changing in the sports world how will it affect college football this season

USA TODAY

Comments made earlier this week by Penn State’s director of athletic medicine suggesting that roughly a third of Big Ten athletes who had contracted COVID-19 and undergone a cardiac scan showed heart-related issues were inaccurate, the university said in a statement shared Thursday evening.

Wayne Sebastianelli, who is also the team doctor for Penn State football, said during a meeting of the State College Area School District board of directors that these cardiac scans showed “30 to roughly 35 percent of their heart muscles” indicated symptoms of myocarditis.

According to a spokesperson in the university’s Office of Marketing and Communications, Sebastianelli was sharing “initial preliminary data that had been verbally shared by a colleague on a forthcoming study, which unbeknownst to him at the time had been published at a lower rate.”

“The research was not conducted by Dr. Sebastianelli or Penn State. Dr. Sebastianelli wishes to clarify this point, and apologize for any confusion,” said the statement.

No cases of myocarditis has been found among Penn State athletes, the university said. In the most recent round of testing, which spanned from Aug. 24-28, 24-28, Penn State conducted 222 COVID-19 tests of students with one positive result.

SEC PREVIEW: Loaded competition for available playoff spots

BIG 12 PREVIEW: Can anyone finally catch up to Oklahoma?

BOWL PROJECTIONS: Two SEC teams in playoff likely when dust settles

Myocarditis, which in severe cases can be fatal, was one of the drivers behind the Big Ten’s decision to postpone the coming season with the possibility to return this winter or spring. 

“There is simply too much we do not know about the virus, recovery from infection, and longer-term effects,” Big Ten Commissioner Kevin Warren wrote last month. “While the data on cardiomyopathy is preliminary and incomplete, the uncertain risk was unacceptable at this time.”

Sebastianelli’s remarks came as Big Ten presidents and chancellors have come under pressure to reconsider last month’s decision, particularly as three other Power Five leagues move ahead as scheduled with the start of their seasons this month.

According to the Mayo Clinic, “In many cases, myocarditis improves on its own or with treatment, leading to a complete recovery.”

Even in mild cases, however, the clinic suggests that “persons should avoid competitive sports for at least three to six months.”

Inflammation can lead to “electrical malaise,” Sebastianelli said, potentially causing arrhythmia, or an irregular heart rhythm. 

“What has been seen across some of the schools is that some of the athletes affected haven’t really recovered their full pulmonary function,” he said. “They just don’t train as hard as they normally can.

“We don’t know how long that’s going to last. What we have seen is when people have been studied with cardiac MRI scans — symptomatic and asymptomatic COVID infections — is a level of inflammation in cardiac muscle that just is alarming.”

Autoplay

Show Thumbnails

Show Captions



Source link

Adrian Woody
Adrian Woody Author
Contributor At Industry News Blog

Having the apt skills to play with words to put forth various updates and news relating to the field of technology in an interesting way has made Adrian is a contributor in our organization. He is dedicated to writing articles related to all the up-to-the-minute inventions, launches, updates, and much more happening in the world of technology. In his free time, Adrian offers a guest lecture to kids about the latest inventions.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *